Akero Therapeutics
AKRO
AKRO
103 hedge funds and large institutions have $626M invested in Akero Therapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 35 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
11% less capital invested
Capital invested by funds: $700M → $626M (-$74.2M)
20% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 35
98% less call options, than puts
Call options by funds: $51K | Put options by funds: $2.3M
Holders
103
Holding in Top 10
2
Calls
$51K
Puts
$2.3M
Top Buyers
| 1 | +$6.83M | |
| 2 | +$5.76M | |
| 3 | +$4.62M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.01M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$896K |
Top Sellers
| 1 | -$5.64M | |
| 2 | -$2.63M | |
| 3 | -$2.6M | |
| 4 |
Two Sigma Investments
New York
|
-$1.82M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.68M |